» Non-Financial

Company Directors
Company Advisors
New & Press Releases
Directors Share Dealings
Major Shareholders
Company Subsidiary Calendar of Future Events
Company Name Change
Company Status Change

» Analyst Spreadsheet

Quick View(PDF)
Trader(PDF)
Dossier(PDF)
Download Analyst Template
Analyst Spreadsheet
Download Master Template
Annual Master Spreadsheet
Quarterly Master Spreadsheet
Annual & Quaterly Master Spreadsheet
Valuation Model Template
Valuation Model Spreadsheet
Business Risk(PDF)
Credit Metrics(PDF)
Annual Reports

For all products and/or service inquiries or to learn more about how WVB customer service solutions can reduce your service costs while increasing customer satisfaction, email us at .

ROCHE HOLDING

WVB Number : CHE000001482 Country : Swiss Confederation (Switzerland)
SIC categorization : PHARMACEUTICAL PREPARATIONS (2834) ISIN : CH0012032113, CH0012032048
FT categorization : DRUGS (433)  
Company status: ACTIVE  

» Corporation Profile :

Profile in brief:
The Company is a health-care company active in the discovery, development, manufacture and marketing of novel health-care solutions. Its products and services address prevention, diagnosis and treatment of diseases.
Phone : 41 61 688 11 11 Fax : 61 691 93 91
Chairman: : N/A Auditor : KPMG AG
CEO/Managing Director : SEVERIN SCHWAN

» Company Facts

Net Profit Margin (%) 24.51  
Operating Margin (%) 31.78  
Return on Assets (%) 16.89  
Return on Equity (%) 37.80  
Employees 101,465  

» Company Financials

  Annual (2020)
Income Statement
('000 CHF )
Sales/Total Revenue 58,323,000  
EBITDA 23,751,000  
EBIT 18,542,000  
Net Income 14,295,000  
Balance Sheet
( '000 CHF)
Total Current Assets 32,942,000  
Total Assets 86,138,000  
Current Liabilities 25,401,000  
Total Liabilities & Debt 46,365,000  
Total Equity 39,773,000  
Cash & Flow
( '000 CHF)
Net Income/Staring Line 15,068,000  
Cash from Operating 18,566,000  
Cash from Investing -9,067,000  
Cash from Financing -9,666,000  
Cash & Equivalent Yr End 5,727,000